NIS-observe Treatment Efficacy in Maintaining Symptoms Control in Moderate/Severe Asthma With Symbicort SMART

AstraZeneca

Status: Completed

Conditions: Moderate/Severe Asthma

Study type: Observational

Funder types: Industry

Identifiers

NCT00785733

NIS-RRO-SYM-2008/1

Details and patient eligibility

About

The primary objective of this non-interventional study is to evaluate efficacy of Symbicort® SMART treatment in adult patients with moderate to severe asthma using ACQ scores during 6 months period

Enrollment: 1,182 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients eligible for entry into study are the patients diagnosed with moderate to severe asthma, that the doctors have already decided to treat with Symbicort SMART within the last month, before inclusion in this program
• All eligible patients will be included in the protocol provided they will receive detailed information in advance and will sign consent to grant access to their own data collected during this programme.

Exclusion criteria

• All the patients who have a known hypersensitivity to Symbicort or any of its excipients will not be included in this study.
• As per valid Romanian SmPC, concomitant medication, that could result in drug interactions and could jeopardise patient safety will be carefully considered before having the patient enrolled.

Trial design

1,182 participants in 1 patient group

1

Description:

Moderate and severe asthma patients stabilized on Symbicort SMART